Identification of early molecular markers for breast cancer
2011

Identifying Early Markers for Breast Cancer

Sample size: 19 publication 10 minutes Evidence: moderate

Author Information

Author(s): Kretschmer Céline, Sterner-Kock Anja, Siedentopf Friederike, Schoenegg Winfried, Schlag Peter M, Kemmner Wolfgang

Primary Institution: Charité Comprehensive Cancer Center

Hypothesis

Can we identify molecular markers that allow early detection of ductal carcinoma in situ (DCIS) in breast cancer?

Conclusion

The study identified seven genes that may help in the early detection of DCIS and invasive breast carcinomas.

Supporting Evidence

  • Seven genes were significantly up-regulated in DCIS-bearing mice.
  • Similar up-regulation of these genes was observed in human DCIS samples.
  • Quantitative RT-PCR confirmed the enhanced expression of the identified marker genes.

Takeaway

The researchers found some genes that can help doctors catch breast cancer early, which is really important for treating it successfully.

Methodology

Gene expression profiling was performed on transgenic mice and human samples, followed by validation using quantitative RT-PCR and immunohistochemistry.

Potential Biases

Potential bias due to the limited sample size and reliance on specific mouse models.

Limitations

The study was limited by the small number of human DCIS samples available for analysis.

Participant Demographics

The human cohort consisted of nine DCIS, five invasive ductal carcinoma (IDC), and five healthy control samples.

Statistical Information

P-Value

0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/1476-4598-10-15

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication